Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

SMMTSMMT
Showing 8 of 12 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in SUMMIT THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 1.9M shares of SMMT (SUMMIT THERAPEUTICS INC), worth $27.7M as of 2026-Q2. The position was increased (+247.3% shares). SMMT represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$27.7M

Current Shares

1.9M

Total Value Change

+$18.3M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+247.3%
$27.7M0.0%$14.57
46
2026-Q1
Increased
548,335
+990.2%
$10.4M0.0%$15.11
45
2025-Q4
Decreased
50,298
-74.2%
$879,7120.0%$17.49
0
2025-Q3
New
194,851
-
$4M0.0%$21.16
37
2025-Q2
Exited
0
-100.0%
$00.0%$20.60
0
2025-Q1
Increased
1.7M
+339.8%
$32.9M0.1%$20.32
47
2024-Q4
Decreased
387,242
-10.2%
$6.9M0.0%$17.89
0
2024-Q3
Decreased
431,176
-57.3%
$9.4M0.0%$20.89
0

Other major holders of SMMT: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used